Shree Pushkar Chemicals & Fertilizers Ltd Q3 FY26 Earnings Analysis

- Shree Pushkar expects continued quarter-on-quarter improvement in Chemicals segment, with Unit 5 starting next year enhancing growth. - For FY26, the company conservatively targets around Rs. 1,000 crore revenue with ~8% PAT margin, showing confidence based on H1 performance. - Post-capex, the new facility at Meghnagar (Rs. 350 crore) expected to generate Rs. 1,200 crore revenue conservatively, potentially Rs. 1,500-1,600 crore at full capacity. - Combined with Units 5, 6, and 8 expansions, revenue could reach Rs. 2,500 to 3,000 crore by FY29. - Chemical segment volumes grew 11.3% YoY and 16.4% sequentially in Q2 FY26; management believes growth momentum will continue despite market volatility. - Fertilizer segment utilization around 70%, expected to increase to 75%, but full capacity is practically challenging. - Solar capacity expansion (totaling 20.6 MW DC) will improve operational efficiency and cost savings, indirectly supporting profitability.

- Shree Pushkar projects revenue of around Rs. 1,000 crores for FY26 with a PAT margin of approximately 7.5% to 8%. - The company expects quarter-on-quarter improvement in the chemical segment, anticipating better performance with the commissioning of Unit 5 next year. - Expansion plans, including a Rs. 350 crore capex for Unit 8 (300,000 MTA capacity) targeted for commissioning by FY28, are expected to boost revenues to Rs. 1,200 crores conservatively from this facility alone. - Combining existing and upcoming units (Unit 5, 6, and 8), turnover visibility for FY29 ranges between Rs. 2,500 to Rs. 3,000 crores. - EBITDA margins are expected to remain stable around 11%-12%, with scope to improve towards 10% or higher. - The company is funding expansions mainly through internal accruals, maintaining a strong balance sheet and liquidity. - Solar capacity expansion will improve cost efficiency, supporting profitability growth.

- Rs. 350 crores capex announced for Unit 8 with capacity of 300,000 MTA, focused on fertilizers including NPK, expected completion around March 2028. - Unit 6 expansion includes a 66,000 MTPA acid complex with improved capacity and specialized production. - Unit 5 is set to start next year, contributing to further improvements. - Solar power expansion: 10 MW at Shree Pushkar and 1.10 MW at Kisan Phosphates, totaling around 11.10 MW DC, expected to start in December/January to reduce power costs. - Future capex primarily funded through internal accruals and a Rs. 30 crores preferential allotment from promoters. - Backward integration included in Unit 8 capex for raw materials like phosphoric acid (100% in-house). - Expansion aims to increase revenue potential to Rs. 1,200 - 1,600 crores from Unit 8 alone. - Conservative revenue projection: Rs. 2,500 crores by FY29 combining Unit 5, 6, and 8 capacities.

- Current expansions, including Unit 5, Unit 6, and the new Unit 8 facility, are primarily funded through internal accruals. - The company has deployed approximately Rs. 400 crores of its own funds toward capex so far. - The new Rs. 350 crore capex for Unit 8 will be funded mostly via internal accruals and a Rs. 30 crore preferential allotment from promoters. - There is no mention of raising funds through debt; bank funding levels have remained stable and manageable. - The company emphasized strong financial management, aiming to avoid excessive external borrowing. - Preferential allotments to promoters are being used for incremental funding, but no new broad equity fundraising or debt issuance plans were indicated.

The transcript on page 17 and surrounding pages does not provide specific details regarding the current or expected order book or pending orders for Shree Pushkar Chemicals & Fertilisers Limited. However, the management's comments indicate: - The company is confident about sustained improvements quarter-on-quarter, especially with the upcoming Unit 5 starting next year, which will enhance performance. - There is visibility and a positive market outlook expected to drive growth, implying a healthy demand pipeline. - No explicit numbers or specific information about order book or pending orders were disclosed during the call. - The management emphasizes stability and sustainability in their business model to meet demand despite external headwinds. For detailed order book information, the investor relations team (Churchgate Partners) may be contacted as noted in the closing remarks.